The highs and lows of blood glucose aren't just an energy rollercoaster; they could be a key to detecting diabetes risk early ...

Topline data were announced from a phase 3 trial evaluating orforglipron in adults with T2D and inadequate glycemic control with diet and exercise alone.

Simulations using mathematical models further supported why AC_Var — a CGM-derived index — could detect declines in glycemic control earlier than traditional indicators such as fasting glucose. In ...